AIHealthcare

Intuitive Surgical, Inc. is a publicly traded medical-technology company headquartered in Sunnyvale, California. Founded in 1995, it develops, manufactures, and markets robotic-assisted, minimally invasive surgery platforms—principally the da Vinci surgical system and the Ion endoluminal system—along with related instruments, accessories, services, and digital technologies. Its AI-healthcare relevance is primarily through computer-assisted surgery, imaging, data, and software capabilities integrated into robotic platforms; the available sources do not establish the company as a standalone AI company. Intuitive is a global leader and pioneer in robotic-assisted surgery, with more than 3.2 million procedures performed using its products in 2025, including more than 3.1 million da Vinci procedures. It reported approximately $10.1 billion in 2025 revenue and spent more than $1 billion on research and development. Intuitive is publicly listed on Nasdaq under ISRG, so recent capital formation is through public markets rather than a conventional venture-funding round; no recent private funding round was identified.